Research Topic · Peer-Reviewed

Acute Myeloid Leukemia

Acute Myeloid Leukemia, commonly referred to as AML, is a type of cancer that starts in the bone marrow and affects white blood cells. This aggressive form of cancer can quickly spread to other parts of the body, including the lymph nodes, spleen, liver, and brain. AML is caused by the abnormal growth and accumulat…

Curated from this journal's research 📚 11 peer-reviewed articles cited Cited 21× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed June 2026

Overview

Acute Myeloid Leukemia, commonly referred to as AML, is a type of cancer that starts in the bone marrow and affects white blood cells. This aggressive form of cancer can quickly spread to other parts of the body, including the lymph nodes, spleen, liver, and brain. AML is caused by the abnormal growth and accumulation of immature white blood cells, known as myeloid blasts. These blasts interfere with the normal production of healthy blood cells, leading to a decrease in the number of red blood cells, white blood cells, and platelets in the body. As a result, patients with AML may experience symptoms such as fatigue, weakness, infections, and bleeding. Treatment for AML typically involves a combination of chemotherapy, radiation therapy, and stem cell transplantation. However, new therapies such as targeted drug therapy and immunotherapy are also being developed. Research in hematology and oncology is essential to improve the understanding of the disease and develop new treatments. Scientists are investigating the genetic mutations that trigger AML, studying the microenvironment of the cancer cells, and testing new therapies in clinical trials. The Hematology Oncology Research Group is dedicated to advancing the understanding of AML and other types of cancers through interdisciplinary research. Their work not only has the potential to improve the prognosis for patients with AML but could also have implications for other types of cancers. By utilizing the latest scientific techniques and technologies to understand the disease, researchers can identify new strategies to treat AML and ultimately improve patient outcomes.

Research published in this journal

11 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2015

Epigenetics and Nutrition

Exact topic International Journal of Nutrition Cited by 2 doi:10.14302/issn.2379-7835.ijn-14-603

How this research is being cited

The 11 articles above have been cited 21 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Acute Myeloid Leukemia, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.